NewsDesk @bactiman63 Last week, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate...

NewsDesk  @infectiousdiseasenews New York City health officials announced Tuesday the availability of the oral antiviral treatment for symptomatic COVID-19, Paxlovid,  to treat mild-to-moderate COVID-19...

NewsDesk  @infectiousdiseasenews The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study. However, lab...

NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) for the treatment...